Sponsors (2)
The bill improves nationwide labeling clarity and allergen protection by restricting 'egg' market names to products that meet a statutory/biological definition and by requiring FDA guidance, but it imposes compliance costs, market disruption, and reduced naming/marketing options that could hurt plant‑based producers, shrink consumer choice, and raise prices for some shoppers.
People with egg allergies and the general public: labeling that restricts use of 'egg' market names to products meeting a statutory/biological definition will make it easier to identify real-egg products and reduce accidental allergen exposure and consumer confusion.
Consumers and small food businesses: a nationwide statutory standard for when foods may use 'egg' market names creates more uniform labeling rules across states, reducing marketplace confusion and protecting consumers from misleading names.
Manufacturers, regulators, and consumers: requiring FDA guidance (draft in 180 days, final in 1 year) and a nationwide rule reduces regulatory uncertainty and improves enforceability across jurisdictions.
Small food manufacturers and plant-based producers: will face significant reformulation, relabeling, compliance costs, and potential penalties or enforcement actions to meet the new egg-product definition, which could reduce margins or force products off shelves.
Consumers who avoid eggs for dietary, ethical, or other reasons: availability and choice of plant‑based 'egg' alternatives could shrink if products are removed from interstate commerce or rebranded, limiting options for those consumers.
Retailers and consumers: the transition period could cause market disruption and short‑term confusion as existing products are relabeled, reformulated, or withdrawn while agencies and firms implement new guidance.
Based on analysis of 4 sections of legislative text.
Prohibits using "egg" or "egg product" market names in interstate commerce unless the food is an avian egg or meets federal egg-product definitions, and requires FDA guidance and a report to Congress.
Introduced September 30, 2025 by Elise M. Stefanik · Last progress September 30, 2025
Prohibits marketing or selling any food in interstate commerce using an "egg" or "egg product" market name unless the food actually meets a statutory definition tied to avian eggs or established federal egg-product definitions. Directs FDA to issue draft guidance within 180 days and final guidance within 1 year, nullifies conflicting prior agency guidance, and requires an FDA/USDA report to Congress within 2 years describing enforcement actions and next steps if misbranded products remain in commerce. The law makes such labeling a form of misbranding under the Federal Food, Drug, and Cosmetic Act and authorizes the FDA to use existing warning, penalty, and enforcement authorities to remove or penalize nonconforming products. It primarily affects producers and sellers of egg substitutes and plant-based alternatives, poultry egg producers, retailers, and federal regulators.